# H5 Vaccine Alone or With Adjuvant in Healthy Adults

> **NCT00296634** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 600 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Aluminum hydroxide
- **BIOLOGICAL:** Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur pre-adsorbed)

## Key facts

- **NCT ID:** NCT00296634
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2010-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296634, "H5 Vaccine Alone or With Adjuvant in Healthy Adults". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT00296634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*